MyFinsight
Home
Blog
About
Short-term marketable
securities
$197,158K
(-17.67%↓ Y/Y)
Cash and cash
equivalents
$111,039K
(8.07%↑ Y/Y)
Trade receivables,
net of allowances
$76,920K
(19.13%↑ Y/Y)
Prepaid expenses and
other current assets
$41,374K
(72.08%↑ Y/Y)
Inventory
$13,185K
(7.40%↑ Y/Y)
Total current assets
$439,676K
(-0.78%↓ Y/Y)
Long-term marketable
securities
$236,451K
(36.85%↑ Y/Y)
Deferred tax assets, net
$178,680K
(10.14%↑ Y/Y)
Strategic inventory
$18,956K
(137.22%↑ Y/Y)
Operating lease
right-of-use asset
$6,860K
(38.20%↑ Y/Y)
Property and equipment,
net
$5,133K
(118.61%↑ Y/Y)
Other assets
$2,946K
(-64.52%↓ Y/Y)
Total assets
$888,702K
(10.85%↑ Y/Y)
Total liabilities and
stockholders equity
$888,702K
(10.85%↑ Y/Y)
Total stockholders
equity
$705,776K
(11.01%↑ Y/Y)
Total liabilities
$182,926K
(10.24%↑ Y/Y)
Treasury stock
$998,013K
(15.12%↑ Y/Y)
Additional paid-in capital
$1,048,598K
(16.40%↑ Y/Y)
Total current
liabilities
$153,802K
(6.32%↑ Y/Y)
Long-term accrued income
taxes
$15,488K
(-1.21%↓ Y/Y)
Long-term operating lease
liability
$7,504K
(34.29%↑ Y/Y)
Long-term accrued
government rebates
$6,132K
Retained earnings
$654,613K
(9.21%↑ Y/Y)
Accumulated other
comprehensive income
$436K
(-80.97%↓ Y/Y)
Common stock
$142K
(2.90%↑ Y/Y)
Accrued and other
liabilities
$115,347K
(26.65%↑ Y/Y)
Accrued research and
development expenses
$21,628K
(-25.55%↓ Y/Y)
Accounts payable
$14,910K
(-36.62%↓ Y/Y)
Short-term operating lease
liability
$1,917K
(88.50%↑ Y/Y)
Back
Back
Balance Sheet
CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT)
source: myfinsight.com